Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction.

Law AH, Lee DC, Yuen KY, Peiris M, Lau AS.

Cell Mol Immunol. 2010 Jul;7(4):263-70. doi: 10.1038/cmi.2010.25. Epub 2010 May 17.

2.

Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release.

Nelli RK, Dunham SP, Kuchipudi SV, White GA, Baquero-Perez B, Chang P, Ghaemmaghami A, Brookes SM, Brown IH, Chang KC.

J Virol. 2012 Sep;86(17):9201-10. doi: 10.1128/JVI.00244-12. Epub 2012 Jun 20.

3.

Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses.

Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, Lau YL.

J Infect Dis. 2006 Jul 1;194(1):61-70. Epub 2006 May 26.

PMID:
16741883
4.

Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.

Sun X, Zeng H, Kumar A, Belser JA, Maines TR, Tumpey TM.

J Virol. 2016 Nov 28;90(24):11157-11167. Print 2016 Dec 15.

5.

Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses.

Sakabe S, Iwatsuki-Horimoto K, Takano R, Nidom CA, Le Mt, Nagamura-Inoue T, Horimoto T, Yamashita N, Kawaoka Y.

J Gen Virol. 2011 Jun;92(Pt 6):1428-34. doi: 10.1099/vir.0.030346-0. Epub 2011 Mar 2.

6.
7.
8.

Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.

Lee SM, Gardy JL, Cheung CY, Cheung TK, Hui KP, Ip NY, Guan Y, Hancock RE, Peiris JS.

PLoS One. 2009 Dec 14;4(12):e8072. doi: 10.1371/journal.pone.0008072.

9.

A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection.

O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S.

PLoS One. 2011 Mar 9;6(3):e17377. doi: 10.1371/journal.pone.0017377.

10.

H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades.

Hui KP, Lee SM, Cheung CY, Mao H, Lai AK, Chan RW, Chan MC, Tu W, Guan Y, Lau YL, Peiris JS.

J Infect Dis. 2011 Dec 15;204(12):1866-78. doi: 10.1093/infdis/jir665. Epub 2011 Oct 19.

PMID:
22013225
11.

CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.

Teng O, Chen ST, Hsu TL, Sia SF, Cole S, Valkenburg SA, Hsu TY, Zheng JT, Tu W, Bruzzone R, Peiris JS, Hsieh SL, Yen HL.

J Virol. 2016 Dec 16;91(1). pii: e01813-16. Print 2017 Jan 1.

12.

Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.

Haasbach E, Droebner K, Vogel AB, Planz O.

J Interferon Cytokine Res. 2011 Jun;31(6):515-25. doi: 10.1089/jir.2010.0071. Epub 2011 Feb 16.

PMID:
21323570
13.

Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses.

Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr.

Med Microbiol Immunol. 2011 Feb;200(1):53-60. doi: 10.1007/s00430-010-0173-y. Epub 2010 Sep 24.

PMID:
20865277
14.

Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.

Nakayama M, Shichinohe S, Itoh Y, Ishigaki H, Kitano M, Arikata M, Pham VL, Ishida H, Kitagawa N, Okamatsu M, Sakoda Y, Ichikawa T, Tsuchiya H, Nakamura S, Le QM, Ito M, Kawaoka Y, Kida H, Ogasawara K.

PLoS One. 2013 Dec 23;8(12):e82740. doi: 10.1371/journal.pone.0082740. eCollection 2013.

15.

Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-κB and p38 MAPK signaling pathways.

Pan H, Zhang Y, Luo Z, Li P, Liu L, Wang C, Wang H, Li H, Ma Y.

Am J Physiol Lung Cell Mol Physiol. 2014 Jan;306(2):L183-95. doi: 10.1152/ajplung.00147.2013. Epub 2013 Nov 15.

16.

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.

Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2013 Mar;94(Pt 3):583-92. doi: 10.1099/vir.0.048652-0. Epub 2012 Nov 14.

PMID:
23152369
17.

Proinflammatory cytokine response and viral replication in mouse bone marrow derived macrophages infected with influenza H1N1 and H5N1 viruses.

Chan RW, Leung CY, Nicholls JM, Peiris JS, Chan MC.

PLoS One. 2012;7(11):e51057. doi: 10.1371/journal.pone.0051057. Epub 2012 Nov 30.

18.

Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages.

Friesenhagen J, Boergeling Y, Hrincius E, Ludwig S, Roth J, Viemann D.

J Leukoc Biol. 2012 Jul;92(1):11-20. doi: 10.1189/jlb.0911479. Epub 2012 Mar 21.

19.

[Swine influenza virus: evolution mechanism and epidemic characterization--a review].

Qi X, Lu C.

Wei Sheng Wu Xue Bao. 2009 Sep;49(9):1138-45. Review. Chinese.

PMID:
20030049
20.

Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection.

Sun Y, Li C, Shu Y, Ju X, Zou Z, Wang H, Rao S, Guo F, Liu H, Nan W, Zhao Y, Yan Y, Tang J, Zhao C, Yang P, Liu K, Wang S, Lu H, Li X, Tan L, Gao R, Song J, Gao X, Tian X, Qin Y, Xu KF, Li D, Jin N, Jiang C.

Sci Signal. 2012 Feb 21;5(212):ra16. doi: 10.1126/scisignal.2001931.

Supplemental Content

Support Center